Guidebook · Question desk

Ask for answers beyond the label.

Keep these questions beside you during a visit. Ask for plain answers and write down what still needs to be checked.

The misconception

Misconception: “research use only” means the product has been checked for people.

What holds up

A research label does not answer your care questions.

As of September 2026, no BPC-157 product has FDA approval for people, including products described as being for research.

Ask about the ingredient, the evidence, and who is responsible for each part of care. The label cannot supply those answers.

Which exact version of BPC-157 would I receive?
The BPC-157 name can refer to more than one version of the ingredient. FDA treats the two versions it reviewed as different ingredients. It warns that unclear names could leave you with something the doctor did not order. Ask for the full ingredient name on the doctor’s order and on the pharmacy label; they should match.
Who would make and send it?
Get the name of the pharmacy or business that would make the medicine so you can check its licence. Ask how that name will appear on any paperwork.
What rule allows the pharmacy to make medicine with that ingredient?
Ask the pharmacy to name the current rule, say which requirement this exact ingredient meets, and show where you can check that in official records.
What tests were done on the medicine being offered?
Ask about unwanted substances, germs, and bacterial toxins, which are poisons from bacteria. A certificate of analysis is a report of tests on a batch, meaning medicine made at one time. A purity figure says how much of the tested sample is the named ingredient; it does not answer all these questions.

What studies in people match my health problem?
Ask what the study measured and what it was compared with. Then ask about the evidence for the other options discussed.
What information still needs an exam or a test?
Ask who arranges it and how its findings will change the conversation.
Which person can answer my questions once the visit ends?
Medical-board guidance current as of September 2026 says patients need a way to ask their treating health professional more questions once the visit ends.
What is the full quote, including any ongoing charges?
Ask what happens to the bill if no treatment is offered. Keep the cancellation terms with the quote.

Write down the answer in your own words. Mark “still unclear” wherever a term, claim, or charge was not explained.

If the discussion runs ahead of you, ask to return to that point. Leave with the next step written down.

FDA review: ingredient identity and batch tests
FDA found requests that named one BPC-157 version but attached test papers for the other. Most test papers it reviewed gave a purity figure without showing checks for unwanted substances.
Medical-board guidance: questions after care
Read the section on questions from patients and choosing a treatment on a website.